1 |
Kleine-tebbe J, Brans R, Jappe U. Allergene - Auslöser der verschiedenen Allergievarianten. Allergo J 2022;31:16-31. [DOI: 10.1007/s15007-022-4980-4] [Reference Citation Analysis]
|
2 |
Mizutani H, Nguyen J, Tam MM, Tate B, Cahill J, Nixon R. Patch test reactivity to iodopropynyl butylcarbamate between 2011 and 2018 in Melbourne, Australia. Contact Dermatitis 2021. [PMID: 34228361 DOI: 10.1111/cod.13930] [Reference Citation Analysis]
|
3 |
Boonstra M, Rustemeyer T, Middelkamp-Hup MA. Both children and adult patients with difficult-to-treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized. J Eur Acad Dermatol Venereol 2018;32:1554-61. [PMID: 29578626 DOI: 10.1111/jdv.14973] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
4 |
Johnson W. Iodopropynyl Butylcarbamate. Int J Toxicol 2017;36:37S-8S. [DOI: 10.1177/1091581817717642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
5 |
Giménez-arnau A, Deza G, Bauer A, Johnston G, Mahler V, Schuttelaar M, Sanchez-perez J, Silvestre J, Wilkinson M, Uter W. Contact allergy to preservatives: ESSCA* results with the baseline series, 2009-2012. J Eur Acad Dermatol Venereol 2017;31:664-71. [DOI: 10.1111/jdv.14063] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 9.5] [Reference Citation Analysis]
|
6 |
Hartwig A, MAK Commission. 3-Iodo-2-propynyl butylcarbamate [MAK Value Documentations, 2002]. The MAK-Collection for Occupational Health and Safety 2016. [DOI: 10.1002/3527600418.mb5540653kske3416] [Reference Citation Analysis]
|
7 |
Iodopropynyl butylcarbamate. Meyler's Side Effects of Drugs 2016. [DOI: 10.1016/b978-0-444-53717-1.00912-4] [Reference Citation Analysis]
|
8 |
Yim E, Baquerizo Nole KL, Tosti A. Contact Dermatitis Caused by Preservatives. Dermatitis 2014;25:215-31. [DOI: 10.1097/der.0000000000000061] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
|
9 |
Tan C, Rasool S, Johnston GA. Contact dermatitis: Allergic and irritant. Clinics in Dermatology 2014;32:116-24. [DOI: 10.1016/j.clindermatol.2013.05.033] [Cited by in Crossref: 96] [Cited by in F6Publishing: 100] [Article Influence: 10.7] [Reference Citation Analysis]
|
10 |
Choulis N. Dermatological drugs, topical agents, and cosmetics. A worldwide yearly survey of new data in adverse drug reactions and interactions 2014. [DOI: 10.1016/b978-0-444-62635-6.00014-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
11 |
. 3-Iodpropinylbutylcarbamat [MAK Value Documentation in German language, 2002]. The MAK-Collection for Occupational Health and Safety 2012. [DOI: 10.1002/3527600418.mb5540653kskd0034] [Reference Citation Analysis]
|
12 |
Davies RF, Johnston GA. New and emerging cosmetic allergens. Clinics in Dermatology 2011;29:311-5. [DOI: 10.1016/j.clindermatol.2010.11.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
|
13 |
Lindberg M, Matura M. Patch Testing. In: Johansen JD, Frosch PJ, Lepoittevin J, editors. Contact Dermatitis. Berlin: Springer Berlin Heidelberg; 2011. pp. 439-64. [DOI: 10.1007/978-3-642-03827-3_24] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
|
14 |
Adverse immunological effects of drugs other than anticance drugs and drugs used in immunology. Meyler's Side Effects of Drugs in Cancer and Immunology 2010. [DOI: 10.1016/b978-0-444-53267-1.50011-3] [Reference Citation Analysis]
|
15 |
Maier LE, Lampel HP, Bhutani T, Jacob SE. Hand dermatitis: a focus on allergic contact dermatitis to biocides. Dermatol Clin 2009;27:251-64, v-vi. [PMID: 19580920 DOI: 10.1016/j.det.2009.05.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
|
16 |
. How to use the reaction index and positivity ratio. Contact Dermatitis 2008;59:63-5. [DOI: 10.1111/j.1600-0536.2008.01360.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
17 |
Scheman A, Jacob S, Zirwas M, Warshaw E, Nedorost S, Katta R, Cook J, Castanedo-tardan MP. Contact Allergy: Alternatives for the 2007 North American Contact Dermatitis Group (NACDG) Standard Screening Tray. Disease-a-Month 2008;54:7-156. [DOI: 10.1016/j.disamonth.2007.10.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
|
18 |
Schnuch A, Geier J, Uter W, Basketter DA, Jowsey IR. The biocide polyhexamethylene biguanide remains an uncommon contact allergen.: Recent multicentre surveillance data. Contact Dermatitis 2007;56:235-9. [DOI: 10.1111/j.1600-0536.2007.01089.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
|
19 |
Mowad CM. Cosmetic allergic contact dermatitis: an update. Expert Review of Dermatology 2007;2:79-86. [DOI: 10.1586/17469872.2.1.79] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
20 |
Davis RF, Johnston GA. Iodopropynyl butylcarbamate contact allergy from wood preservative. Contact Dermatitis 2007;56:112-112. [DOI: 10.1111/j.1600-0536.2007.00970.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
21 |
Wahlberg JE, Lindberg M. Patch Testing. Contact Dermatitis. [DOI: 10.1007/3-540-31301-x_22] [Cited by in Crossref: 101] [Cited by in F6Publishing: 97] [Article Influence: 5.9] [Reference Citation Analysis]
|
22 |
Biebl KA, Warshaw EM. Allergic Contact Dermatitis to Cosmetics. Dermatologic Clinics 2006;24:215-32. [DOI: 10.1016/j.det.2006.01.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
|
23 |
Geier J, Lessmann H. Metalworking Fluids. Contact Dermatitis 2006. [DOI: 10.1007/3-540-31301-x_33] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
24 |
Iodopropynylbutylcarbamate. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 2006. [DOI: 10.1016/b0-44-451005-2/00360-0] [Reference Citation Analysis]
|
25 |
Geier J, Lessmann H, Uter W, Schnuch A. Patch testing with phenylmercuric acetate. Contact Dermatitis 2005;53:117-8. [PMID: 16033409 DOI: 10.1111/j.0105-1873.2005.0650d.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
26 |
Mahler V. Entwicklungen und Trends der Kontaktallergene. Fortschritte der praktischen Dermatologie und Venerologie 2005. [DOI: 10.1007/3-540-28691-8_24] [Reference Citation Analysis]
|
27 |
Siebert J. The sensitizing potential of iodopropynyl butylcarbamate in the local lymph node assay. Contact Dermatitis 2004;51:318-9. [DOI: 10.1111/j.0105-1873.2004.0459j.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
28 |
Brasch J, Schnuch A, Geier J, Aberer W, Uter W; German Contact Dermatitis Research Group (DKG), The Information Network Of Departments Of Dermatology (IVDK). Iodopropynylbutyl carbamate 0.2% is suggested for patch testing of patients with eczema possibly related to preservatives. Br J Dermatol 2004;151:608-15. [DOI: 10.1111/j.1365-2133.2004.06141.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
|
29 |
Sasseville D. Hypersensitivity to preservatives. Dermatol Ther 2004;17:251-63. [DOI: 10.1111/j.1396-0296.2004.04028.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 3.9] [Reference Citation Analysis]
|
30 |
Schnuch A, Lessmann H, Geier J, Frosch PJ, Uter W. Contact allergy to fragrances: frequencies of sensitization from 1996 to 2002. Results of the IVDK*. Contact Dermatitis 2004;50:65-76. [DOI: 10.1111/j.0105-1873.2004.00302.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 134] [Article Influence: 7.1] [Reference Citation Analysis]
|
31 |
Mulder W, Meinardi M. Dermatological drugs and topical agents. Side Effects of Drugs Annual 2004. [DOI: 10.1016/s0378-6080(04)80021-7] [Reference Citation Analysis]
|
32 |
Geier J, Lessmann H, Frosch PJ, Pirker C, Koch P, Aschoff R, Richter G, Becker D, Eckert C, Uter W, Schnuch A, Fuchs T. Patch testing with components of water-based metalworking fluids. Contact Dermatitis 2003;49:85-90. [DOI: 10.1111/j.0105-1873.2003.00187.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
|
33 |
Geier J, Uter W, Lessmann H, Schnuch A. The positivity ratio--another parameter to assess the diagnostic quality of a patch test preparation. Contact Dermatitis 2003;48:280-2. [PMID: 12868978 DOI: 10.1034/j.1600-0536.2003.00033.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 117] [Article Influence: 5.8] [Reference Citation Analysis]
|
34 |
Erdmann SM, Merk HF. [Contact sensitization to external agents]. Hautarzt 2003;54:331-7. [PMID: 12669204 DOI: 10.1007/s00105-003-0517-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
35 |
Jensen CD, Thormann J, Andersen KE. Airborne allergic contact dermatitis from 3-iodo-2-propynyl-butylcarbamate at a paint factory. Contact Dermatitis 2003;48:155-7. [PMID: 12755730 DOI: 10.1034/j.1600-0536.2003.00079.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
|